Impact of Thymidine Phosphorylase on Cancer Treatment
Author Information
Author(s): Marchetti S, Chazal M, Dubreuil A, Fischel J L, Etienne M C, Milano G
Primary Institution: Centre Antoine Lacassagne, Nice
Hypothesis
The study investigates the roles of thymidine phosphorylase in enhancing the effectiveness of fluoropyrimidine drugs and its impact on tumor growth.
Conclusion
Thymidine phosphorylase overexpression enhances sensitivity to certain cancer drugs but has a modest effect on tumor growth.
Supporting Evidence
- Thymidine phosphorylase enhances the cytotoxic effects of 5′DFUR and 5FU.
- There was a significant correlation between TP activity and sensitivity to 5′DFUR.
- The effect of TP on tumor growth was modest and mainly in the early stages.
Takeaway
This study looks at a protein that helps cancer drugs work better, but it doesn't make tumors grow much slower.
Methodology
The study involved transfecting a rat carcinoma cell line with thymidine phosphorylase and assessing drug sensitivity and tumor growth.
Limitations
The impact of thymidine phosphorylase on tumor growth was only observed in the initial stages.
Participant Demographics
BDIX rats were used in the study.
Statistical Information
P-Value
0.0002
Statistical Significance
p=0.0002
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website